收藏切换
Clinical study of propofol combined with sufentanil for intravenous anesthesia in children undergoing laparoscopic repair of oblique inguinal hernia
收藏切换
PDF
Ping HAN, Rui-chao CHU, Yan ZHANG
Chinese Journal of Clinical Pharmacology | 2025, 41(18) : 2624 - 2629
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(18): 2624-2629
Clinical and Basic Bridging Research
Clinical study of propofol combined with sufentanil for intravenous anesthesia in children undergoing laparoscopic repair of oblique inguinal hernia
Full
Ping HAN, Rui-chao CHU, Yan ZHANG
Affiliations
  • Department of Anesthesiology, Shandong Maternal and Child Health Hospital Affiliated to Qingdao University, Jinan 250031, Shandong Province, China
Published: 2025-09-28 doi: 10.13699/j.cnki.1001-6821.2025.18.009
Outline
收藏切换
Objective

To observe clinical curative effect and safety of propofol emulsion injection combined with sufentanil citrate injection for intravenous anesthesia in children undergoing laparoscopic repair of oblique inguinal hernia.

Methods

According to historical medication regimens, children undergoing laparoscopic repair of oblique inguinal hernia were divided into treatment group and control group. The control group was given intravenous pumping of propofol emulsion injection 4-10 mg·kg-1·h-1 and fentanyl citrate injection 3 μg·kg-1·h-1 for anesthesia maintenance, while treatment group was given intravenous pumping of propofol emulsion injection 4-10 mg·kg-1·h-1 and sufentanil citrate injection 0.3 μg·kg-1·h-1 for anesthesia maintenance. The hemodynamic indexes, emergence agitation, awakening quality, pain and postoperative analgesics use were compared between the two groups at different time points, and safety evaluation was performed.

Results

According to electronic medical record, 427 children with oblique inguinal hernia were enrolled between June 2021 and 2024. Finally, 160 cases meeting the inclusion and exclusion criteria were included for grouping analysis, including 76 cases in control group and 84 cases in treatment group. Immediately after skin incision (T1), heart rate (HR) in treatment group and control group were (92.67±5.06) and (97.53±4.97) time·min-1, and mean arterial pressure (MAP) were (98.63±5.82) and (101.31±5.49) mmHg, respectively. At 5 min after the start of surgery (T2), HR in treatment group and control group were (89.35±5.22) and (94.21±5.36) time·min-1, and MAP were (96.97±5.13) and (99.29±4.75) mmHg, respectively. After the surgery (T3), HR in treatment group and control group were (87.41±4.89) and (89.82±4.61) time·min-1, and MAP were (93.82±5.67) and (96.71±5.03) mmHg, respectively. The incidences of emergence agitation in treatment group and control group were 3.57% (3 cases/84 cases) and 11.84% (9 cases/76 cases), awakening time were (8.21±1.76) and (10.45±2.59) min, recovery time of spontaneous respiration were (6.29±1.40) and (8.63±2.02) min, and extubation time were (12.43±2.51) and (15.87±3.08) min, respectively; immediately after awakening, scores of the face, legs, activity, cry, consolability behavioral tool (FLACC) in treatment group and control group were (2.08±0.59) and (2.43±0.65) points; at 1 h after awakening, FLACC scores were (1.75±0.47) and (2.12±0.61) points; at 6 h after awakening, FLACC scores were (1.42±0.41) and (1.73±0.49); at 12 h after awakening, FLACC scores were (1.28±0.36) and (1.56±0.43) points, and differences in the above indexes between the two groups were statistically significant (all P<0.05). The total dosages of postoperative analgesics in treatment group and control group were (33.51±3.21) and (41.98±3.94) mL, and compression frequency of analgesic pump was (1.55±0.42) and (2.89±0.75) times, the differences were statistically significant (all P<0.05). The adverse drug reactions were as follows: treatment group: nausea, hypotension, vomiting, dizziness; control group: nausea, hypotension, vomiting, dizziness. There was no significant difference in total incidence of adverse drug reactions between treatment group and control group [10.71% (9 cases/84 cases) vs. 9.21% (7 cases/76 cases), (P>0.05)].

Conclusion

Compared with propofol emulsion injection combined with fentanyl citrate injection, propofol emulsion injection combined with sufentanil citrate injection for intravenous anesthesia is beneficial to maintain hemodynamic stability, improve emergence agitation and awakening quality, relieve postoperative pain and reduce postoperative use of analgesics in children undergoing laparoscopic repair of oblique inguinal hernia, which has good safety.

sufentanil citrate injection  /  propofol emulsion injection  /  intravenous anesthesia  /  child  /  repair of oblique inguinal hernia
Ping HAN, Rui-chao CHU, Yan ZHANG. Clinical study of propofol combined with sufentanil for intravenous anesthesia in children undergoing laparoscopic repair of oblique inguinal hernia[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (18) : 2624 -2629 . DOI: 10.13699/j.cnki.1001-6821.2025.18.009
Year 2025 volume 41 Issue 18
PDF
525
397
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.18.009
  • Receive Date:2025-05-11
  • Online Date:2026-08-05
  • Published:2025-09-28
Article Data
Affiliations
History
  • Received:2025-05-11
Affiliations
    Department of Anesthesiology, Shandong Maternal and Child Health Hospital Affiliated to Qingdao University, Jinan 250031, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.18.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT